Hatch, Alexander Expected To Helm Health Panels In Senate
This article was originally published in The Tan Sheet
Executive Summary
Orrin Hatch, the supplement industry’s chief congressional ally and veteran of major pharmaceutical legislative initiatives, is in line to head the Finance Committee with Republican control of the Senate. The HELP Committee – with jurisdiction over public health – could be Lamar Alexander’s first chair opportunity.
You may also be interested in...
Senior Senators Seek Details On Government Audits Of 340B Entities
Top Republicans on two Senate health committees are joined by House members in seeking answers on an HHS review of entities receiving 340B drug discounts, including the process and consequences of audits and decertification.
Pink Sheet Podcast: Relyvrio And Public Promises, Allergy Biomarker Adcomms, PMDA In The USA
Pink Sheet reporters and editor discuss the implications of Amylyx following through on its pledge to remove Relyvrio from the market after its trial failed, an FDA idea to bring potential biomarkers for promising allergy and asthma treatments to advisory committees, and Japan’s PMDA opening an office in Washington D.C.
Pink Sheet Podcast: Mifepristone And Misinformation At SCOTUS, Understanding US FDA’s ODAC
Pink Sheet reporters and editor discuss the upcoming US Supreme Court arguments on mifepristone access, the SCOTUS reaction to the fight against misinformation, and the FDA’s Oncologic Drugs Advisory Committee going against three negative product reviews.